Operating out of beautiful Bozeman, Montana, Alercell, Inc is a molecular diagnostics company that provides cancer and leukemia rapid tests to diagnose these life-threatening illnesses at an early stage. The company was founded with the aim of providing more accurate and timely diagnostic tools for cancer patients worldwide.
Alercell's mission is to make a difference in the fight against cancer by providing innovative and accurate diagnostic solutions that improve patient outcomes.
Alercell's products are based on cutting-edge technology that enables the early detection of cancer and Leukemia. The company's flagship product, the Alercell Leukemia Rapid Test, is a next generation sequencing-based test that can detect Leukemia genes in just a few hours. This diagnostic tool can be used by healthcare professionals to diagnose Leukemia patients quickly and accurately, allowing them to start treatment as soon as possible.
Innovative technology for a broader reach
With its focus on improving patient outcomes and providing more accurate diagnostic solutions, Alercell is at the forefront of cancer research and development. The company continues to invest in innovative technologies and has a strong pipeline of products that are being developed for diagnostic testing. Our product line includes rapid COVID-19 tests as well. Our products have been sold directly to blood banks, hospitals, commercial labs, and testing sites worldwide. Alercell operates within the United States, with manufacturing and storage sites in Europe and Asia, further expanding our worldwide reach and accessibility. Our goal is to make our products available to as many people as possible, so that we can make a difference in the fight against cancer.
The Alercell mission is built on the foundation of “stopping it before it starts”. Our genetics based testing is the first line of assault against cancer & leukemia and infectious disease. We utilize cutting edge technology such as DNA sequencing to develop a myriad of rapid testing tools that are used to discover major disease in the earliest stages. Every new innovation grows from a driving principle of prevention through discovery.
Delos M. Cosgrove, MD